Kenneth A. Freedberg
Harvard Medical School and Massachusetts General Hospital
Kenneth A. Freedberg, M.D., MSc, is a Professor of Medicine at Harvard Medical School and Director of the Program in Epidemiology and Outcomes Research at the Harvard Medical School's Division of AIDS, and Director of the HIV Research Program in the Division of General Medicine at Massachusetts General Hospital. In 2000, he joined the Divisions of General Medicine and Infectious Diseases at the Massachusetts General Hospital to develop a program in HIV epidemiology and outcomes research. Dr. Freedberg's research interests include decision analysis, cost-effectiveness analysis, and clinical epidemiology, particularly related to HIV clinical care and policy. He is or has been principal investigator on projects sponsored by NIAID, NIMH, CDC, AHRQ, and HRSA. Much of his work centers around The Cost-effectiveness of Preventing AIDS Complications (CEPAC) group, which he directs, in collaboration with investigators at Harvard School of Public Health, Boston University, Yale University, Weill Cornell Medical College, and University of Tourcoing in Lille, France. This effort has now expanded to include investigators in South Africa, Côte d'Ivoire, India, Mexico, and the Organization of Eastern Caribbean States (OECS). Dr. Freedberg is former Chair of the AIDS Clinical Trials Group (ACTG) Outcomes Committee and has developed efforts to incorporate clinical economic analysis into AIDS clinical trials on a national level. In 1984, he earned his M.D. from Harvard Medical School, followed in 1989, by an MSc in Health Services Administration from the Harvard School of Public Health.